DiamondRock Hospitality Company is a real estate investment trust . The company has market cap of $2.37 billion. As of December 31, 2016, the Company owned a portfolio of 26 hotels and resorts that contains 9,472 guest rooms located in 17 different markets in North America and the United States Virgin Islands. It has a 20.23 P/E ratio. The Company’s business is to acquire, own, asset manage and renovate hotel properties in the United States.
The stock of TG Therapeutics Inc (NASDAQ:TGTX) is a huge mover today! About 3.74M shares traded or 93.78% up from the average. TG Therapeutics Inc (NASDAQ:TGTX) has risen 42.66% since September 16, 2016 and is uptrending. It has outperformed by 31.68% the S&P500.The move comes after 6 months positive chart setup for the $725.21 million company. It was reported on Apr, 25 by Barchart.com. We have $12.83 PT which if reached, will make NASDAQ:TGTX worth $43.51 million more.
TG Therapeutics, Inc. is a biopharmaceutical firm focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. The company has market cap of $725.21 million. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. It currently has negative earnings. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody that targets a specific epitope on the cluster of differentiation (CD20) antigen found on mature B-lymphocytes.
Since December 30, 2016, it had 0 insider purchases, and 3 selling transactions for $206,091 activity. KENNEDY WILLIAM JAMES also sold $87,788 worth of TG Therapeutics Inc (NASDAQ:TGTX) shares. 7,000 shares were sold by Charney Laurence N, worth $78,190. 8,816 shares were sold by Power Sean A, worth $40,113.
Investors sentiment increased to 2.35 in Q4 2016. Its up 1.68, from 0.67 in 2016Q3. It improved, as 5 investors sold TG Therapeutics Inc shares while 15 reduced holdings. 16 funds opened positions while 31 raised stakes. 21.26 million shares or 20.65% less from 26.79 million shares in 2016Q3 were reported. California State Teachers Retirement System holds 0% of its portfolio in TG Therapeutics Inc (NASDAQ:TGTX) for 75,835 shares. Point72 Asia (Hong Kong) Limited holds 0.02% in TG Therapeutics Inc (NASDAQ:TGTX) or 4,485 shares. Blackrock Fund Advisors has 0% invested in TG Therapeutics Inc (NASDAQ:TGTX). Creative Planning holds 31,001 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 2,255 shares. Meeder Asset Inc accumulated 3,386 shares. Tiaa Cref Inv Mngmt Ltd Limited Liability Company holds 0% of its portfolio in TG Therapeutics Inc (NASDAQ:TGTX) for 104,263 shares. Alliancebernstein L P has 0% invested in TG Therapeutics Inc (NASDAQ:TGTX). Teachers Retirement Systems Of The State Of Kentucky has 0.01% invested in TG Therapeutics Inc (NASDAQ:TGTX). Victory Mngmt reported 1,978 shares stake. Voya Inv Mgmt Ltd Liability Corporation reported 14,870 shares. Ra Cap Mngmt Lc stated it has 1.00 million shares. Blackrock Advsrs Ltd Llc has 18,942 shares for 0% of their portfolio. Manufacturers Life Insurance The reported 27,501 shares or 0% of all its holdings. Royal Commercial Bank Of Canada invested in 0% or 1,429 shares.
Among 6 analysts covering TG Therapeutics (NASDAQ:TGTX), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. TG Therapeutics had 8 analyst reports since August 12, 2015 according to SRatingsIntel. On Thursday, October 6 the stock rating was reinitiated by Brean Capital with “Buy”. H.C. Wainwright maintained the stock with “Buy” rating in Tuesday, March 7 report. The rating was reinitiated by H.C. Wainwright on Wednesday, August 12 with “Buy”. The rating was initiated by Suntrust Robinson with “Buy” on Friday, May 27. On Wednesday, September 9 the stock rating was initiated by Raymond James with “Strong Buy”. The firm has “Hold” rating given on Wednesday, August 12 by Zacks. The stock has “Buy” rating by SunTrust on Friday, May 27. The stock has “Outperform” rating by FBR Capital on Tuesday, December 1.
Analysts await TG Therapeutics Inc (NASDAQ:TGTX) to report earnings on May, 9. They expect $-0.40 EPS, down 110.53% or $0.21 from last year’s $-0.19 per share. After $-0.48 actual EPS reported by TG Therapeutics Inc for the previous quarter, Wall Street now forecasts -16.67% EPS growth.
The stock increased 1.05% or $0.12 on April 25, reaching $11.51. About 2.37M shares traded or 4.41% up from the average. DiamondRock Hospitality Company (NYSE:DRH) has risen 23.67% since September 16, 2016 and is uptrending. It has outperformed by 12.68% the S&P500.
Resolution Capital Ltd holds 4.09% of its portfolio in DiamondRock Hospitality Company for 6.08 million shares. Green Street Investors Llc owns 301,500 shares or 3.49% of their US portfolio. Moreover, Eii Capital Management Inc. has 2.14% invested in the company for 587,100 shares. The Alabama-based Mesirow Financial Investment Management has invested 1.36% in the stock. Smith Graham & Co. Investment Advisors Lp, a Texas-based fund reported 929,249 shares.
Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $343,400 activity.
Analysts await DiamondRock Hospitality Company (NYSE:DRH) to report earnings on May, 5. They expect $0.18 earnings per share, down 14.29% or $0.03 from last year’s $0.21 per share. DRH’s profit will be $37.06 million for 15.99 P/E if the $0.18 EPS becomes a reality. After $0.24 actual earnings per share reported by DiamondRock Hospitality Company for the previous quarter, Wall Street now forecasts -25.00% negative EPS growth.
